Publications by authors named "Derick Lau"

Claim this Profile
F
Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer.
Megan E Daly, Derick H Lau, D Gregory Farwell, Quang Luu, Paul J Donald

Am J Otolaryngol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
Allen M Chen, Megan E Daly, D Gregory Farwell, Esther Vazquez, Jean Courquin, Derick H Lau

JAMA Otolaryngol Head Neck Surg· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer.
Cheryl Ho, Angela M Davies, Randeep S Sangha, Derick Lau, Primo Lara, Laurel Beckett

Invest New Drugs· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer.
Yuhchyau Chen, James Moon, Kishan J Pandya, Derick H M Lau, Karen Kelly, Laurie E Gaspar

Front Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population-based clinical trial of irinotecan and Carboplatin.
Derick Lau, Minh Huynh, Jewel Johl

J Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Southwestern oncology group phase II trial (S0526) of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma.
Derick H M Lau, James Moon, Angela M Davies, Rachel E Sanborn, Fred R Hirsch

Clin Lung Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer.
Allen M Chen, Judy Li, Laurel A Beckett, Talia Zhara, Gregory Farwell, Derick H Lau

Laryngoscope· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility study of intra-patient sorafenib dose-escalation or re-escalation in patients with previously treated advanced solid tumors.
Thomas J Semrad, Courtney Eddings, Chong-Xian Pan, Derick H Lau, David Gandara, Laurel Beckett

Invest New Drugs· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensity-modulated radiotherapy is associated with improved global quality of life among long-term survivors of head-and-neck cancer.
Allen M Chen, D Gregory Farwell, Quang Luu, Esther G Vazquez, Derick H Lau

Int J Radiat Oncol Biol Phys· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brachial plexus-associated neuropathy after high-dose radiation therapy for head-and-neck cancer.
Allen M Chen, William H Hall, Judy Li, Laurel Beckett, D Gregory Farwell, Derick H Lau

Int J Radiat Oncol Biol Phys· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voice quality after organ-preservation therapy with definitive radiotherapy for laryngeal cancer.
Valerie H Lau, Rebecca J Leonard, Susan Goodrich, Quang Luu, D Gregory Farwell, Derick H Lau

Head Neck· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.
Joseph Chao, Timothy W Synold, Robert J Morgan, Charles Kunos, Jeff Longmate, Derick H Lau

Cancer Chemother Pharmacol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial.
Randeep Sangha, Angela M Davies, Primo N Lara, Philip C Mack, Laurel A Beckett, Derick Lau

J Thorac Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
Allen M Chen, D Gregory Farwell, Derick H Lau, Bao-Qing Li, Quang Luu

Int J Radiat Oncol Biol Phys· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escalating weekly doses of cetuximab and correlation with skin toxicity: a phase I study.
Cheryl Ho, Randeep Sangha, Laurel Beckett, Michael Tanaka, Derick H Lau

Invest New Drugs· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome.
Allen M Chen, Leon M Chen, Andrew Vaughan, Radhika Sreeraman, D Gregory Farwell, Derick H Lau

Int J Radiat Oncol Biol Phys· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary radiation therapy for head-and-neck cancer in the setting of human immunodeficiency virus.
Emily A Klein, Michael Guiou, D Gregory Farwell, Quang Luu, Derick H Lau

Int J Radiat Oncol Biol Phys· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial.
Primo N Lara, Jeff Longmate, Karen Reckamp, Barbara Gitlitz, Athanassios Argiris, Derick H M Lau

Clin Lung Cancer· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
Allen M Chen, Bao-Qing Li, Derick H Lau, D Gregory Farwell, Quang Luu

Int J Radiat Oncol Biol Phys· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late esophageal toxicity after radiation therapy for head and neck cancer.
Allen M Chen, Bao-Qing Li, Richard L S Jennelle, Derick H Lau, Claus C Yang

Head Neck· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAS0811: from combinatorial chemistry to activation of antioxidant response element.
Ming Zhu, Hyounggee Baek, Ruiwu Liu, Aimin Song, Kit Lam, Derick Lau

J Biomed Biotechnol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.
Baoqing Li, Dan Li, Derick H Lau, D Gregory Farwell, Quang Luu

Radiat Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent erlotinib in combination with pemetrexed: phase I schedules designed to achieve pharmacodynamic separation.
Angela M Davies, Cheryl Ho, Laurel Beckett, Derick Lau, Sidney A Scudder

J Thorac Oncol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of irinotecan and carboplatin for extensive or relapsed small-cell lung cancer.
Gigi Chen, Minh Huynh, Lou Fehrenbacher, Howard West, Primo N Lara, Derick Lau

J Clin Oncol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel small molecule, LAS-0811, inhibits alcohol-induced apoptosis in VL-17A cells.
Tae-Hun Kim, Senthil K Venugopal, Ming Zhu, Si-Si Wang, Derick Lau

Biochem Biophys Res Commun· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis